Concentration in Health Economics and Policy
Recent Graduates and Dissertation Titles
| Graduate Name | Dissertation Title | Current Position |
|---|---|---|
| Mark Meiselbach (2022) | Market Factors Influencing the Choice and Generosity of Health Insurance Plans Offered to Employees | Assistant Professor, Bloomberg School of Public Health |
| Brendan Rabideau (2022) | Essays on Telemedicine and Mental Health during the COVID-19 Pandemic | Associate, Analysis Group |
| Yang Wang (2022) | The Impact of Increasing Private Insurance Payment Rates and ACA Medicaid Expansion on Hospital Behaviors and Patient Experience | Assistant Scientist, Bloomberg School of Public Health |
| Debbie Bozzi (2021) | Indirect Effects of Financial Incentives on Physician Behavior in Perinatal Care | Senior Researcher, Health Care Cost Institute |
| Sonal Parasrampuria (2019) | The Impact of Health Insurance Generosity on Beneficiary Costs, Utilization and Outcomes | FDA Team Lead and Social Science Analyst, Office of the Assistant Secretary for Planning and Evaluation (ASPE), HHS |
| Shawn Du (2019) | Consumer Decision-Making in the Health Insurance Marketplace | Associate Director, Real World Value & Evidence -Oncology, Johnson and Johnson |
| Caroline Hanson (2019) | The Relationship between Insurance Market Concentration and Healthcare Use and Quality: An Exploration of the Role of Market Dynamics, Patient Demand, and Physician Incentives | Principal Analyst, Congressional Budget Office |
| Taruja D. Karmarkar (2018) | The Value of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C in an Integrated Healthcare System | Associate Director, Policy Research, Merck |
| Roza Vazin (2018) | Essays on Strategies to Reduce Potentially Avoidable Hospital Utilization in Maryland | Director of Data Science and Analytics, Amino Health |
| Nicolae Done (2017) | The Effects of Global Budget Payments on Hospital Utilization and Quality in Rural Maryland | Manager, Analysis Group |
| Ilene L. Hollin (2016) | Patient-Centered Benefit Risk (PCBR) assessment in Drug Development: An Application for Rare Diseases | Assistant Professor, Temple University |
| Ellen Janssen (2017) | Measuring Treatment Preferences of People with Type 2 Diabetes, An Application of Stated-Preference Methods | Director, Janssen Pharmaceutical |
| Susan T. Yeh Beyer (2016) | Essays on the Federal Financing of the Medicare and Medicaid Programs | Principal Analyst, Congressional Budget Office |
| Eric T. Roberts (2015) | Essays on Markets for Primary Care Services for Medicaid Adults | Assistant Professor, University of Pittsburg |
| Christine Buttorff (2014) | The Impact of Value-Based Insurance Design on those with Multiple Chronic Conditions: An Examination of Maryland's High-Risk Insurance Pool | Policy Researcher, RAND |
| Jason G. Matheny (2013) | The Economics of Pharmaceutical Development: Costs, Risks and Incentives | President and Chief Executive Officer, RAND |
| Erin E. Trish (2013) | Essays on Competition in US Private Health Insurance Markets | Co-director and Associate Professor, USC Schaeffer Center for Health Policy & Economics |
| Ricky Brathwaite (2013) | The Impact of Race and Lifestyle -dependent Exposures on Health State Preferences and the Implication for Health System Utilization | CEO, Bermuda Health Council |
| Frederic Selk (2013) | Essays on Physician Behavior | Partner, Bates White |